Revolutionizing Veterinary Cancer Screening: Nu.Q® Vet Cancer Test Launches in Japan
VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a globally recognized epigenetics company, has joined forces with Fujifilm Vet Systems Co. Ltd (“Fujifilm Vet Systems”), a premier provider of veterinary diagnostic solutions, to introduce the Nu.Q® Vet Cancer Test to the Japanese market.
Expanding Veterinary Nu.Q® Cancer Screening in Japan
Under the terms of the supply agreement, Volition empowers Fujifilm Vet Systems to distribute and conduct cancer screening services for canines utilizing the Nu.Q® Vet Cancer Test across its network of central reference laboratories in Japan. This innovative test serves as an accessible and cost-effective tool for early cancer detection in dogs.
Empowering Japanese Veterinarians with Cutting-Edge Technology
Dr. Tom Butera, CEO of Volition Veterinary Diagnostics Development LLC, expressed excitement about the collaboration: “Partnering with Fujifilm Vet Systems allows us to reach Japanese veterinarians through a trusted network of ten laboratories, servicing clinics and hospitals nationwide.”
He continued, “With the Nu.Q® Vet Cancer Test, Japanese veterinarians gain access to advanced screening technology for early cancer detection, enhancing patient outcomes and care. Our test offers simplicity and ease of use, seamlessly integrating into preventive care programs and complementing routine bloodwork during wellness visits.”
Strategic Expansion in the Asian Market
Dr. Jasmine Kway, CEO of Singapore Volition, emphasized the strategic significance of entering the Japanese market: “Japan presents a substantial opportunity for Volition as we expand our Nu.Q® Vet Cancer Test offerings in Asia. Collaborating with Fujifilm Vet Systems enables us to introduce our innovative test nationwide, leveraging their extensive diagnostic laboratory network.”
Kiyotaka Fujiwara, COO of Fujifilm Vet Systems, echoed the sentiment, stating, “We are pleased to enhance our diagnostic service portfolio with the Nu.Q® Vet Cancer Test, catering to Japanese veterinarians’ evolving needs. Our commitment to providing timely and comprehensive testing services remains unwavering.”
Energetic Demons Make a Splash on Opening Day of Spring Practice
About Volition: Pioneering Epigenetics in Healthcare
Volition is a global leader in epigenetics, dedicated to advancing disease detection and monitoring for humans and animals. Through its subsidiaries, Volition develops and commercializes non-invasive blood tests to facilitate early diagnosis and treatment monitoring for various diseases, including cancer and conditions associated with NETosis, such as sepsis.
With research and development hubs in Belgium, the U.S., London, and Singapore, Volition is committed to improving patient outcomes and quality of life through innovative healthcare solutions.
About FUJIFILM VET Systems: Driving Excellence in Veterinary Diagnostics
FUJIFILM VET Systems specializes in providing comprehensive testing services to veterinary medical facilities nationwide. With a network of ten contract laboratories across Japan, the company ensures prompt and efficient delivery of test results, earning accolades from veterinarians for its reliability and convenience.